Literature DB >> 11416042

Comparative analysis of pharmacologic and/or genetic disruption of cyclooxygenase-1 and cyclooxygenase-2 function in female reproduction in mice.

J Reese1, X Zhao, W G Ma, N Brown, T J Maziasz, S K Dey.   

Abstract

Cyclooxygenase (COX)-derived prostaglandins are critical in female reproduction. Gene targeting studies show that ovulation, fertilization, implantation, and decidualization are defective in COX-2 deficient mice. We used genetic and pharmacologic approaches to perturb COX function and examine the differential and synergistic effects of inhibition of COX-1, COX-2, or of both isoforms on reproductive outcomes during early pregnancy in mice. The results demonstrate that simultaneous inhibition of COX-1 and COX-2 produces more severe effects on early pregnancy events than inhibition of either isoform alone. The effects of pharmacological inhibition of COX-2 on female reproductive functions were less severe than the null mutation of the COX-2 gene. A combined approach showed that COX-2 inhibition in COX-1(-/-) mice induced complete reproductive failure, suggesting a lack of alternative sources of prostaglandin synthesis. This investigation raises caution regarding the indiscriminate use of COX inhibitors and shows for the first time the distinct and overlapping pathways of the cyclooxygenase systems in female reproduction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11416042     DOI: 10.1210/endo.142.7.8307

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  30 in total

Review 1.  The COXes of Danio: from mechanistic model to experimental therapeutics.

Authors:  Stephen M Prescott; H Joseph Yost
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-01       Impact factor: 11.205

2.  Cyclooxygenase-1-derived PGE2 promotes cell motility via the G-protein-coupled EP4 receptor during vertebrate gastrulation.

Authors:  Yong I Cha; Seok-Hyung Kim; Diane Sepich; F Gregory Buchanan; Lilianna Solnica-Krezel; Raymond N DuBois
Journal:  Genes Dev       Date:  2006-01-01       Impact factor: 11.361

3.  Ablation of cyclooxygenase-2 in forebrain neurons is neuroprotective and dampens brain inflammation after status epilepticus.

Authors:  G E Serrano; N Lelutiu; A Rojas; S Cochi; R Shaw; C D Makinson; D Wang; G A FitzGerald; R Dingledine
Journal:  J Neurosci       Date:  2011-10-19       Impact factor: 6.167

4.  Effect of the combination of a cyclooxygenase-1 selective inhibitor and taxol on proliferation, apoptosis and angiogenesis of ovarian cancer in vivo.

Authors:  Wei Li; Mei-Lin Liu; Jia-Hui Cai; Yun-Xian Tang; Ling-Yun Zhai; Jun Zhang
Journal:  Oncol Lett       Date:  2012-04-23       Impact factor: 2.967

5.  Differential impact of prostaglandin H synthase 1 knockdown on platelets and parturition.

Authors:  Ying Yu; Yan Cheng; Jinjin Fan; Xin-Sheng Chen; Andres Klein-Szanto; Garret A Fitzgerald; Colin D Funk
Journal:  J Clin Invest       Date:  2005-03-17       Impact factor: 14.808

6.  Cyclooxygenase-1 is a potential target for prevention and treatment of ovarian epithelial cancer.

Authors:  Takiko Daikoku; Dingzhi Wang; Susanne Tranguch; Jason D Morrow; Sandra Orsulic; Raymond N DuBois; Sudhansu K Dey
Journal:  Cancer Res       Date:  2005-05-01       Impact factor: 12.701

7.  Effects of a selective cyclooxygenase-1 inhibitor in SKOV-3 ovarian carcinoma xenograft-bearing mice.

Authors:  Wei Li; Zhong-lei Ji; Guang-chao Zhuo; Ru-jun Xu; Jie Wang; Hong-ru Jiang
Journal:  Med Oncol       Date:  2009-02-24       Impact factor: 3.064

8.  Effects of a cyclooxygenase-1-selective inhibitor in a mouse model of ovarian cancer, administered alone or in combination with ibuprofen, a nonselective cyclooxygenase inhibitor.

Authors:  Wei Li; Ru-Jun Xu; Zhen-Yun Lin; Guang-Chao Zhuo; Hong-He Zhang
Journal:  Med Oncol       Date:  2008-11-06       Impact factor: 3.064

9.  Effects of cyclooxygenase inhibitors on survival time in ovarian cancer xenograft-bearing mice.

Authors:  Wei Li; Xiao-Li Xu; Jun Zhang; Jia-Hui Cai; Yun-Xian Tang
Journal:  Oncol Lett       Date:  2012-09-20       Impact factor: 2.967

10.  Mammalian target of rapamycin complex 1 and cyclooxygenase 2 pathways cooperatively exacerbate endometrial cancer.

Authors:  Takiko Daikoku; Jumpei Terakawa; Md M Hossain; Mikihiro Yoshie; Monica Cappelletti; Peiying Yang; Lora H Ellenson; Sudhansu K Dey
Journal:  Am J Pathol       Date:  2014-07-21       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.